id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0081-0012,FDA,FDA-2004-E-0081,Patent Term Extension Application - Exhibit C - Patent Maintenance Fees,Supporting & Related Material,APP-Application,2008-11-06T05:00:00Z,2008,11,,,2008-11-06T12:59:23Z,,0,0,090000648046edc0
FDA-2004-E-0081-0010,FDA,FDA-2004-E-0081,USPTO to Medtronic Vascular - Certificate Extending Patent Term,Other,CEP-Certificate Extending Patent Term,2008-11-06T05:00:00Z,2008,11,2008-11-06T05:00:00Z,,2008-11-06T12:58:53Z,,0,0,09000064806a7630
FDA-2004-E-0081-0008,FDA,FDA-2004-E-0081,Medtronic Vascular - Patent Term Extension Application,Other,APP-Application,2008-11-06T05:00:00Z,2008,11,2008-11-06T05:00:00Z,,2008-11-06T12:58:50Z,,0,0,090000648046edc3
FDA-2004-E-0081-0013,FDA,FDA-2004-E-0081,Patent Term Extension Application - Exhibit B - Patent,Supporting & Related Material,APP-Application,2008-11-06T05:00:00Z,2008,11,,,2008-11-06T12:59:24Z,,0,0,090000648046edc1
FDA-2004-E-0081-0011,FDA,FDA-2004-E-0081,Patent Term Extension Application - Exhibit D - Terminal Disclaimer under 37CFR1.321(b) and (c),Supporting & Related Material,APP-Application,2008-11-06T05:00:00Z,2008,11,,,2008-11-06T12:59:22Z,,0,0,090000648046edbf
FDA-2004-E-0081-0007,FDA,FDA-2004-E-0081,Determination of Regulatory Review Period for Purposes of Patent Extension; S8 OVER-THE WIRE SYSTEM - Federal Register Notice,Notice,N-Notice,2008-11-06T05:00:00Z,2008,11,2008-11-06T05:00:00Z,2007-04-25T03:59:59Z,2008-11-06T12:58:48Z,,0,0,090000648046edc8
FDA-2004-E-0081-0014,FDA,FDA-2004-E-0081,Patent Term Extension Application - Exhibit A,Supporting & Related Material,APP-Application,2008-11-06T05:00:00Z,2008,11,,,2008-11-06T12:59:25Z,,0,0,090000648046edc2
FDA-2004-E-0081-0009,FDA,FDA-2004-E-0081,USPTO to Medtronic Vascular - Notice of Final Determination and Requirement for Election,Other,LET-Letter,2008-11-06T05:00:00Z,2008,11,2008-11-06T05:00:00Z,,2008-11-06T12:58:52Z,,0,0,090000648050c7a7
FDA-2004-E-0081-0006,FDA,FDA-2004-E-0081,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2007-09-18T04:00:00Z,2007,9,,,2008-06-24T16:39:06Z,,0,0,090000648046edc9
FDA-2004-E-0081-0005,FDA,FDA-2004-E-0081,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2007-02-07T05:00:00Z,2007,2,,,2008-06-24T16:37:24Z,,0,0,090000648046edc7
FDA-2004-E-0081-0004,FDA,FDA-2004-E-0081,USPTO to FDA/CDER - Letter,Other,LET-Letter,2007-01-09T05:00:00Z,2007,1,,,2008-06-24T16:35:40Z,,0,0,090000648046edc6
FDA-2004-E-0081-0003,FDA,FDA-2004-E-0081,FDA/CDER to the USPTO - Letter,Other,LET-Letter,2006-02-28T05:00:00Z,2006,2,,,2008-06-24T16:33:47Z,,0,0,090000648046edc5
FDA-2004-E-0081-0001,FDA,FDA-2004-E-0081,USPTO to Medtronic Vascular - Letter,Other,LET-Letter,2004-07-14T04:00:00Z,2004,7,,,2008-06-24T16:31:14Z,,0,0,090000648046edb9
FDA-2004-E-0081-0002,FDA,FDA-2004-E-0081,USPTO to FDA/CDER - Letter,Other,LET-Letter,2004-07-14T04:00:00Z,2004,7,,,2008-06-24T16:32:22Z,,0,0,090000648046edc4